Literature DB >> 19455038

Using benefit-cost ratio to select Universal Newborn Hearing Screening test criteria.

Heather L Porter1, Stephen T Neely, Michael P Gorga.   

Abstract

OBJECTIVES: Current protocols presumably use criteria that are chosen on the basis of the sensitivity and specificity rates they produce. Such an approach emphasizes test performance but does not include societal implications of the benefit of early identification. The purpose of the present analysis was to evaluate an approach to selecting criteria for use in Universal Newborn Hearing Screening (UNHS) programs that uses benefit-cost ratio (BCR) to demonstrate an alternative method to audiologists, administrators, and others involved in UNHS protocol decisions.
DESIGN: Existing data from more than 1200 ears were used to analyze BCR as a function of Distortion Product Otoacoustic Emission (DPOAE) level. These data were selected because both audiometric and DPOAE data were available on every ear. Although these data were not obtained in newborns, this compromise was necessary because audiometric outcomes (especially in infants with congenital hearing loss) in neonates are either lacking or limited in number. As such, it is important to note that the characteristics of responses from the group of subjects that formed the bases of the present analyses are different from those for neonates. This limits the extent to which actual criterion levels can be selected but should not affect the general approach of using BCR as a framework for considering UNHS criteria. Estimates of the prevalence of congenital hearing loss identified through UNHS in 37 states and U.S. territories in 2004 were used to calculate BCR. A range of estimates for the lifetime monetary benefits and yearly costs for UNHS were used, based on data available in the literature. Still, exact benefits and costs are difficult to know. Both one-step (DPOAE alone) and two-step (DPOAE followed by automated auditory brainstem response, AABR) screening paradigms were considered in the calculation of BCR. The influence of middle ear effusion was simulated by incorporating a range of expected DPOAE level reductions into an additional BCR analyses
RESULTS: Our calculations indicate that for a range of proposed benefit and cost estimates, the monetary benefits of both one-step (DPOAE alone) and two-step (DPOAE followed by AABR) NHS programs outweigh programmatic costs. Our calculations indicate that BCR is robust in that it can be applied regardless of the values that are assigned to benefit and cost. Maximum BCR was identified and remained stable regardless of these values; however, it was recognized that the use of maximum BCR could result in reduced test sensitivity and may not be optimal for use in UNHS programs. The inclusion of secondary AABR screening increases BCR but does not alter the DPOAE criterion level at which maximum BCR occurs. The model of middle ear effusion reduces overall DPOAE level, subsequently lowering the DPOAE criterion level at which maximum BCR was obtained
CONCLUSION: BCR is one of several alternative methods for choosing UNHS criteria, in which the evaluation of costs and benefits allows clinical and societal considerations to be incorporated into the pass/refer decision in a meaningful way. Although some of the benefits of early identification of hearing impairment cannot be estimated through a monetary analysis, such as improved psychosocial development and quality of life, this article provides an alternative to audiologists and administrators for selecting UNHS protocols that includes consideration of societal implications of UNHS screening criteria. BCR suggests that UNHS is a worthwhile investment for society as benefits always outweigh costs, at least for the estimations included in this article. Although the use of screening criteria that maximize BCR results in lower test sensitivity compared with other criteria, BCR may be used to select criteria that result in increased test sensitivity and still provide a high, although not maximal, BCR. Using BCR analysis provides a framework in which the societal implications of NHS protocols are considered and emphasizes the value of UNHS.

Entities:  

Mesh:

Year:  2009        PMID: 19455038      PMCID: PMC2705472          DOI: 10.1097/AUD.0b013e3181a26f11

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  46 in total

1.  Some issues relevant to establishing a universal newborn hearing screening program.

Authors:  M P Gorga; K Preissler; J Simmons; L Walker; B Hoover
Journal:  J Am Acad Audiol       Date:  2001-02       Impact factor: 1.664

2.  Identification of neonatal hearing impairment: distortion product otoacoustic emissions during the perinatal period.

Authors:  M P Gorga; S J Norton; Y S Sininger; B Cone-Wesson; R C Folsom; B R Vohr; J E Widen; S T Neely
Journal:  Ear Hear       Date:  2000-10       Impact factor: 3.570

3.  Community based universal neonatal hearing screening by health visitors using otoacoustic emissions.

Authors:  M Owen; M Webb; K Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

4.  The societal costs of severe to profound hearing loss in the United States.

Authors:  P E Mohr; J J Feldman; J L Dunbar; A McConkey-Robbins; J K Niparko; R K Rittenhouse; M W Skinner
Journal:  Int J Technol Assess Health Care       Date:  2000       Impact factor: 2.188

5.  The New York State universal newborn hearing screening demonstration project: introduction and overview.

Authors:  B A Prieve; F Stevens
Journal:  Ear Hear       Date:  2000-04       Impact factor: 3.570

6.  Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance.

Authors:  S J Norton; M P Gorga; J E Widen; R C Folsom; Y Sininger; B Cone-Wesson; B R Vohr; K Mascher; K Fletcher
Journal:  Ear Hear       Date:  2000-10       Impact factor: 3.570

7.  A prospective study of the cost-utility of the multichannel cochlear implant.

Authors:  C S Palmer; J K Niparko; J R Wyatt; M Rothman; G de Lissovoy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-11

8.  Early intervention and language development in children who are deaf and hard of hearing.

Authors:  M P Moeller
Journal:  Pediatrics       Date:  2000-09       Impact factor: 7.124

9.  The severely to profoundly hearing-impaired population in the United States: prevalence estimates and demographics.

Authors:  B B Blanchfield; J J Feldman; J L Dunbar; E N Gardner
Journal:  J Am Acad Audiol       Date:  2001-04       Impact factor: 1.664

10.  Changes in the DP-gram during the preterm and early postnatal period.

Authors:  Carolina Abdala; Sandra I Oba; Rangasamy Ramanathan
Journal:  Ear Hear       Date:  2008-08       Impact factor: 3.570

View more
  4 in total

1.  Universal newborn hearing screening.

Authors:  H Patel; M Feldman
Journal:  Paediatr Child Health       Date:  2011-05       Impact factor: 2.253

2.  Screening infants for hearing impairment in Canada.

Authors:  Antoine Eskander; Blake C Papsin
Journal:  CMAJ       Date:  2014-05-20       Impact factor: 8.262

Review 3.  Universal newborn hearing screening in 2010.

Authors:  Daniel Choo; Jareen Meinzen-Derr
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-10       Impact factor: 2.064

4.  Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique.

Authors:  Rajan Sharma; Yuanyuan Gu; Teresa Y C Ching; Vivienne Marnane; Bonny Parkinson
Journal:  Appl Health Econ Health Policy       Date:  2019-06       Impact factor: 2.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.